Med in Ireland 2019 will play host and showcase the entire spectrum of the Irish MedTech eco-system. The MedTech Innovation Zone will allow guests of the event to discover Ireland’s best up and coming pre-commercial companies and the wide-ranging support system that drives the success of these companies, from funding to collaboration with the research community. This showcase will highlight the vital role played by Research and Innovation in Ireland and how it is at the forefront of indigenous innovating Irish firms.

What Irish supports will be there?

  • Innovation Supports for Industry
  • Technology Gateway Network
  • Enterprise Agencies
  • Technology Centres
  • Trade Associations

What Irish companies will be there?

Company Website Description
AventaMed AventaMed develops novel medical devices which simplify surgery, allowing procedures to move out of the Operating Room and into new sites of service such as the doctor’s office. Our products save time, are less invasive and reduce costs to healthcare providers. The Solo Tympanostomy Tube Device (Solo TTD) is an innovative device designed for the simple, quick and effective insertion of ear tubes in children without the need for general anaesthesia or operating rooms. This all-in-one handheld device is pre-loaded with its own ear tube enabling the surgeon to safely place the tube into the child’s ear, with just one click of the button.


Cala Medical Cala Medical is a developing Cytoflow5, which is an extracorporeal bioreactor cassette which represents a completely new approach for sepsis therapy. Blood is removed and treated to specifically remove a key immune mediator of sepsis and then returned to the patient. Cala Medical is developing Cytoflow5 through regulatory and pilot clinical studies and will seek a preferred partner to market the product globally.


Class Medical Class Medical was spun out of the University of Limerick. The technology (the Trans-Urethral Catheter (TUC) Safety Valve) won the inaugural “Enterprise Ireland Cleveland Clinic Clinical Innovation Award” in 2011. A successful first-in-man study which was completed in June 2017 and published in Urology Gold in May 2018. Results from this study were presented at the American Urology Association (AUA) annual conference, in Boston in May 2017, winning “Best Paper in the Trauma, Reconstruction and Diversion” session. The US and European patents were award in 2016 and 2018. Class Medical also won the Munster Final of the Seed Corn competition in 2018.


Enterasense EnteraSense is developing an innovative sensor technology to detect and monitor Upper Gastrointestinal Bleeding (UGIB). The company has licensed the technology from Brigham and Women’s Hospital and Harvard Medical School and has augmented the Intellectual Property portfolio with further development of the technology.


Loci Orthopaedics Ltd Loci Orthopaedics was founded in 2017 as a spin-out from NUI Galway. The company is developing innovative solutions for unmet clinical needs in orthopaedics.


Metabolomic Diagnostics Metabolomic Diagnostics has developed a screening test, PrePsia™, for Preterm Pre-eclampsia (PE) which delivers a high level of accuracy which is clinically useful. PrePsia™ is a simple blood test performed at the early stages of pregnancy which screens women for risk of Preterm PE. Identification of women at high risk allows health care providers to apply an appropriate personalised prenatal care regime, including preventative drug treatment and a risk-tailored prenatal appointment schedule. The company’s vision is to deliver a comprehensive suite of pregnancy risk prediction tests, which is based on the simultaneous analysis of a collection of biomarkers.


Neurent Medical Neurent Medical is an Irish medical device startup developing a novel therapy that will offer allergic and non-allergic rhinitis patients an alternative, minimally invasive, and more readily accessible treatment to alleviate the two primary symptoms of rhinitis, rhinorrhoea and nasal obstruction. Neurent Medical’s therapy will enable ENT surgeons to treat rhinitis patients in an ENT office setting using only local anaesthesia, removing the complications and costs associated with existing surgical procedures.


ProVerum Medical ProVerum is an early stage medical device startup that has developed a novel, minimally invasive treatment for patients with symptomatic Benign Prostatic Hyperplasia (BPH). BPH is an enlargement of the prostate gland, causing difficulty with urination. BPH is one of the most common medical conditions that affects men, and by age 80, it is estimated that 80% of men suffer from the condition. ProVerum have developed an expander implant that is delivered via direct vision through the urethral lumen.


Rockfield Medical Devices Rockfield Medical is a developer of innovative medical devices which transform the mobility and quality of life of enteral feeding users. Our system is a mechanical pump which delivers enteral feed to the user. Operating independent of any electronics it dramatically reduces the technical support and maintenance costs for our sales partners, transforming the service models for enteral feeding pumps in the industry.


Signum Surgical Signum Surgical Ltd. is a Galway based medical device company developing a solution to treat anal fistulas. An anal fistula is an artificial tunnel that, in the majority of cases, develops from an infection that begins within a blocked anal gland. The condition affects 2 out of every 10,000 people globally. Through close collaboration with expert colorectal surgeons, Signum Surgical has developed the BioHealx device – an intuitive, novel, single use, bioabsorbable implant designed to close the internal fistula opening and allow healing of the fistula tract.